INTRODUCTION
Perivascular epithelioid cell tumors (PEComas) are mesenchymal tumors consisting of perivascular epithelioid cells that can be histologically and immunohistochemically distinguished and are rarely seen. In general, these tumors are seen in women aged around 50 years. The most common location is the retroperitoneum. 1, 2 However, these tumors have been reported in several anatomical regions, including the visceral organs, soft tissues, prostate and broad ligament.
Tumors located in the retroperitoneum grow insidiously and manifest as huge lesions. In 2002, the World Health Organization (WHO) reclassified tumors involving PEComas such that they included angiomyolipoma, clear-cell "sugar" tumor, lymphangioleiomyomatosis, clear-cell myomelanocytic tumor of the ligamentum teres/falciform ligament and PEComa not otherwise specified. Primary PEComas may be benign, malignant or otherwise specified with unknown potential for malignancy. The majority of these tumors are benign with a good prognosis. [1] [2] [3] In this report, we present a patient who was operated to treat a retroperitoneal mass that was diagnosed as a benign PEComa, and who developed abdominal recurrence and pulmonary lymphangioleiomyomatosis.
CASE REPORT
A 42-year-old female patient was seen in October 2014, with complaints of abdominal pain and nausea/vomiting that had been occurring for the last three months. In her medical history, she had been using colchicines for 15 years with the diagnosis of familial Mediterranean fever (FMF).
Abdominal ultrasonography (USG) showed a lesion of cystic appearance that measured 8 cm x 3 cm, starting from the lower pole of the left kidney, which was located anteriorly to the iliopsoas muscle. Computed tomography (CT) scans showed a hypodense lesion that measured 5.5 cm x 9.0 cm x 3.0 cm and was located retroperitoneally. It had a smooth outline, started from the level of the left renal artery and expanded from anterior to the iliopsoas muscle towards an inferior position. The backgrounds of the lesion and iliopsoas muscle were not clearly visible (Figure 1) .
The patient underwent local mass excision. Histopathological examination showed PEComa showed intra-abdominal recurrence and lymphangioleiomyomatosis in the lungs. The pneumothorax was treated by means of chest tube placement.
The patient was also evaluated for a biopsy. However, the intra-abdominal lesions were small and difficult to biopsy.
Treatment with everolimus at 10 mg/day was started. This was well tolerated, except that a grade 1 acneiform rash occurred on the patient's back, which was relieved by means of topical steroid.
Positron emission tomography (PET)-CT indicated minimal regression at the third month of treatment (Figure 2A and B) .
However, the disease had become stable according to the response evaluation criteria in solid tumors (RECIST). 4 Everolimus has been continued for nine months.
DISCUSSION
No optimal treatment approach has been standardized for PEComas.
The standard treatment is surgery plus chemotherapy. It is important to reach negative surgical margins. Chemotherapy forms the basis for treatment and can be combined with radiotherapy. Recently, developments towards targeted treatments have shown promise. [2] [3] [4] [5] PEComas show evidence of mammalian target of rapamycin At the end of the first year, the tumor had regressed almost completely, while at the end of the 16 th month they reported that both the treatment and the response remained the same. 3 In our case, we achieved minimal regression with everolimus.
CONCLUSION
PEComas located retroperitoneally are rarely seen. These lesions are generally confused with stromal tumors. PEComas are tumors with unpredictable behavior. Therefore, these patients require long-term follow-up, even in cases of correct diagnosis and benign PEComa.
